Citigroup Inc Pear Therapeutics, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.99 - $2.91 $604 - $1,778	-611 Reduced 42.37%	831 $0
Q3 2022 Nov 10, 2022	SELL	$0.13 - $2.27 $609 - $10,646	-4,690 Reduced 76.48%	1,442 $3,000
Q2 2022 Aug 10, 2022	BUY	$1.54 - $6.48 $9,366 - $39,411	6,082 Added 12164.0%	6,132 $9,000
Q1 2022 May 12, 2022	BUY	$3.67 - $7.63 $183 - $381	50 New	50 $0

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.